For decades, farmers have relied on antibiotics not only to keep animals healthy and safe from disease, but also as gut health enhancing growth promoters to enable the production of more protein using less environmental inputs.
On the other hand, the overuse of antibiotics has been shown to result in increasing resistance to antibiotics amongst human pathogens. Antibiotic resistant bacterial result in >700,000 human deaths every year.
The European Union bans the use of avoparcin, bacitracin, spiramycin, tylosin and virginiamycin.
Chinese government announces a national plan for 2017-2020 to tackle superbug spread by curbing antibiotic use in livestock.
FDA bans all growth promotion practices that use antibiotics.
Both south-east asian countries ban the practice of growth promotion using antibiotics.
Indian government has banned the use of Colistin in livestock production in an effort to curb superbug spread.
Feed production enterprises order to stop the production of commercial feed for growth-promoting pharmaceutical feed additives
In the USA, the shift to No Antibiotics Ever (NAE ) production costs poultry farmers a 3% increase in production cost.
For swine, cattle and aquaculture species, it is currently infeasible to maintain animal welfare standards without antibiotics.
Different pathogens, management practices and facilities make going antibiotic-free especially hard for Asian farmers.
Building on the advances in synthetic biology, Peptobiotics has created a new class of pathogen management solutions that offer the same efficacy and cost effectiveness as antibiotics, without causing bacterial resistance. We are advancing both therapeutic and growth promoting candidates across poultry, swine and shrimp aquaculture.